{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:26:20Z","timestamp":1783743980858,"version":"3.55.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004001","name":"Guizhou Province Science and Technology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ejmech.2026.118877","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T15:23:11Z","timestamp":1776525791000},"page":"118877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design, synthesis, and anti-glioblastoma multiforme evaluation of novel multikinase inhibitors via a cyclization strategy with potent FAK inhibition"],"prefix":"10.1016","volume":"312","author":[{"given":"Ying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kehui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daili","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3703-6704","authenticated-orcid":false,"given":"Longjia","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118877_bib1","doi-asserted-by":"crossref","first-page":"8596","DOI":"10.1021\/acs.jmedchem.1c01946","article-title":"Glioblastoma: current status, emerging targets, and recent advances","volume":"65","author":"Thakur","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118877_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00401-015-1495-z","article-title":"Gliomatosis cerebri: no evidence for a separate brain tumor entity","volume":"131","author":"Herrlinger","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2026.118877_bib3","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/neuonc\/noab199","article-title":"Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas","volume":"24","author":"Wang","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2026.118877_bib4","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.addr.2018.10.013","article-title":"Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment","volume":"138","author":"Pinel","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2026.118877_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2026.118877_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/neuonc\/nox142","article-title":"Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization","volume":"20","author":"Garnier","year":"2018","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.ejmech.2026.118877_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-Year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejmech.2026.118877_bib8","first-page":"1","article-title":"Intranasal administration of temozolomide conjugated nanoparticles with transcranial magnetic stimulation improves the survival in glioblastoma xenograft models","volume":"1","author":"Koh","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejmech.2026.118877_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106792","article-title":"Design, synthesis and biological evaluation of 4-arylamino-pyrimidine derivatives as focal adhesion kinase inhibitors","volume":"140","author":"Long","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118877_bib10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1021\/acs.jmedchem.4c01786","article-title":"Discovery of N-Trifluoromethylated noscapines as novel and potent agents for the treatment of glioblastoma","volume":"68","author":"Cui","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118877_bib11","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.e14518","article-title":"Therapeutic effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy with concomitant temozolomide alone in children with DIPG: a single-center experience with 82 cases","volume":"38","author":"Lai","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.118877_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115637","article-title":"A new era in brain drug delivery: integrating multivalency and computational optimisation for blood-brain barrier permeation","volume":"224","author":"Porro","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2026.118877_bib13","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-024-08224-z","article-title":"Gliocidin is a nicotinamide-mimetic prodrug that targets glioblastoma","volume":"636","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118877_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111810","article-title":"Progress and prospect in tumor treating fields treatment of glioblastoma","volume":"141","author":"Liu","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2026.118877_bib15","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1021\/jm3016014","article-title":"Fragment-Based discovery of new highly substituted 1H-Pyrrolo 2,3-b - and 3H-Imidazolo 4,5-b -Pyridines as focal adhesion kinase inhibitors","volume":"56","author":"Heinrich","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118877_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1242\/jcs.100115","article-title":"E-cadherin-integrin crosstalk in cancer invasion and metastasis","volume":"126","author":"Canel","year":"2013","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejmech.2026.118877_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41568-021-00340-6","article-title":"Targeting FAK in anticancer combination therapies","volume":"21","author":"Dawson","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.118877_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116913","article-title":"Development of novel focal adhesion kinase (FAK) inhibitors for targeting cancer: structural insights and therapeutic potential","volume":"279","author":"Li","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118877_bib19","doi-asserted-by":"crossref","first-page":"12707","DOI":"10.1021\/acs.jmedchem.0c01059","article-title":"Design, synthesis, and biological evaluation of covalent inhibitors of Focal Adhesion Kinase (FAK) against human malignant glioblastoma","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118877_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41419-021-04107-7","article-title":"PPFIBP1 induces glioma cell migration and invasion through FAK\/Src\/JNK signaling pathway","volume":"12","author":"Dong","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.118877_bib21","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3390\/biomedicines9121789","article-title":"FAK regulates VEGFR2 expression and promotes angiogenesis in triple-negative breast cancer","volume":"9","author":"Shiau","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2026.118877_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217640","article-title":"Pediatric gliomas immunity challenges and immunotherapy advances","volume":"618","author":"Vetsika","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2026.118877_bib23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2015.09.001","article-title":"Nuclear FAK controls chemokine transcription, tregs, and evasion of anti-tumor immunity","volume":"163","author":"Serrels","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.118877_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2025.130424","article-title":"Discovery of a macrocyclic FAK inhibitor GZD-257 for treatment of glioblastoma","volume":"130","author":"Wu","year":"2026","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118877_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1158\/1078-0432.CCR-22-1609","article-title":"Development of combination strategies for focal AdhesionKinase inhibition in Diffuse gastric cancer","volume":"29","author":"Peng","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118877_bib26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jhep.2021.05.018","article-title":"Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation","volume":"75","author":"Song","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2026.118877_bib27","article-title":"Effect of targeting FAK by ifebemtinib and immunogenic cell death of Kras G12C\/G12D inhibition on the efficacy of PD1 blockade","volume":"42","author":"Zhang","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.118877_bib28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41389-018-0032-z","article-title":"Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype","volume":"7","author":"Hirt","year":"2018","journal-title":"Oncogenesis"},{"key":"10.1016\/j.ejmech.2026.118877_bib29","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1158\/1538-7445.AM2025-5518","article-title":"Targeting FAK by Ifebemtinib synergizes with pan RAS inhibitors in treating RAS mutant cancers","volume":"85","author":"Zhang","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118877_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s10020-023-00736-0","article-title":"Neratinib for HER2-positive breast cancer with an overlooked option","volume":"29","author":"Guo","year":"2023","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejmech.2026.118877_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ygyno.2025.03.071","article-title":"Phase II study of avutometinib and defactinib in advanced or recurrent gynecologic mesonephric cancer: interim results","volume":"200","author":"Grisham","year":"2025","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ejmech.2026.118877_bib32","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1186\/s12916-022-02646-0","article-title":"Conteltinib (CT-707) in patients with advanced ALK-Positive non-small cell lung cancer: a multicenter, open-label, first-in-human phase 1 study","volume":"20","author":"Xing","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.ejmech.2026.118877_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113573","article-title":"Design, synthesis, and biological evaluation of 2,4-diamino pyrimidine derivatives as potent FAK inhibitors with anti-cancer and anti-angiogenesis activities","volume":"222","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118877_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116678","article-title":"Targeting focal adhesion kinase (FAK) in cancer therapy: a recent update on inhibitors and PROTAC degraders","volume":"276","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118877_bib35","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3892\/or.2015.3753","article-title":"Cytotoxic and radiosensitizing effects of FAK targeting in human glioblastoma cells In Vitro","volume":"33","author":"Storch","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejmech.2026.118877_bib36","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11060-023-04260-3","article-title":"The PYK2 inhibitor PF-562271 enhances the effect of temozolomide on tumor growth in a C57Bl\/6-Gl261 mouse glioma model","volume":"161","author":"Ortiz-Rivera","year":"2023","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.ejmech.2026.118877_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13065-024-01316-x","article-title":"Combined machine learning models, docking analysis, ADMET studies and molecular dynamics simulations for the design of novel FAK inhibitors against glioblastoma","volume":"18","author":"Zhao","year":"2024","journal-title":"BMC Chem."},{"key":"10.1016\/j.ejmech.2026.118877_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003800","article-title":"Crystal structures of the FAK kinase in complex with TAE226 and related bis-anilino pyrimidine inhibitors reveal a helical DFG conformation","volume":"3","author":"Lietha","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118877_bib39","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1016\/j.apsb.2022.09.022","article-title":"Harnessing the cyclization strategy for new drug discovery","volume":"12","author":"Tang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.118877_bib40","first-page":"131","article-title":"Functionalization of fullerene with 4-benzo-9-crown-3 ether","volume":"30","author":"Borazjani","year":"2023","journal-title":"Indian J. Chem. Technol."},{"key":"10.1016\/j.ejmech.2026.118877_bib41","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1021\/ja993912d","article-title":"Highly active and selective catalysts for the formation of \u03b1-aryl ketones","volume":"122","author":"Fox","year":"2000","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2026.118877_bib42","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1479-5876-12-136","article-title":"An aberrant spliced transcript of focal adhesion kinase is exclusively expressed in human breast cancer","volume":"12","author":"Yao","year":"2014","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.118877_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117288","article-title":"Discovery of noncovalent diaminopyrimidine-based inhibitors for glioblastoma via a dual FAK\/DNA targeting strategy","volume":"286","author":"Wei","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118877_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.156047","article-title":"Catalpol ameliorates liver fibrosis via inhibiting aerobic glycolysis by EphA2\/FAK\/Src signaling pathway","volume":"135","author":"Zhang","year":"2024","journal-title":"Phytomedicine"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426003223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:11:46Z","timestamp":1778735506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426003223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":44,"alternative-id":["S0223523426003223"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118877","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and anti-glioblastoma multiforme evaluation of novel multikinase inhibitors via a cyclization strategy with potent FAK inhibition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118877"}}